Mr. and Mrs. Clayton W. Frye Jr. established the Carolyn Frye-Halloran Brain Tumor Therapy Program in 2000, in memory of their daughter, Carolyn, who that year lost her four-year battle with brain cancer. Until her death, Carolyn had fought her cancer with courage, dignity and strength, while remaining a devoted and loving wife, mother, daughter, sister and friend. The memorial gifts from the Frye family inspired an outpouring of philanthropic support in Carolyn’s name — all dedicated to this program, which advances brain tumor research at the Mass General.
Despite great strides in cancer diagnosis and treatment, brain tumors continue to challenge researchers seeking tools for early detection and cure. The program that honors Carolyn has provided bedrock support to the Mass General team investigating translational approaches to brain tumor diagnosis and therapy. Thanks to its funding, the team has applied promising laboratory discoveries to patient care through clinical trials, trained a new generation of investigators, and conducted seminal discussions of novel therapies through the annual Carolyn Frye-Halloran Symposium.
